Publication | Closed Access

Inhibition of ubiquitin conjugating enzyme UBE2C reduces proliferation and sensitizes breast cancer cells to radiation, doxorubicin, tamoxifen and letrozole

Breast OncologyOncologyMedicineBreast Cancer CellsEnzyme Ube2cBreast CancerAnti-cancer AgentCell BiologyCancer TreatmentPharmacologyRadiation OncologyCancer ResearchTumor BiologyCancer Growth